Beam Therapeutics Eulerpool News

Beam Therapeutics Aktie News

Beam Therapeutics wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Beam Therapeutics News stellen wir hier zusammen.

• 20. Juni ·

  Yahoo
  The FDA Shake-Up Continues, And Could Impact Genetic Medicines
• 20. Juni ·

  SeekingAlpha
  Beam Therapeutics: Progress Of BEAM-101 Presses Forward With H2 2025 Data Releases
• 17. Juni ·

  Yahoo
  Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover
• 13. Juni ·

  Yahoo
  Beam Therapeutics Announces New Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 Supporting Differentiated Profile in Sickle Cell Disease (SCD) at European Hematology Association (EHA) 2025 Congress
• 5. Juni ·

  Yahoo
  Beam Therapeutics (BEAM) Up 5.7% Since Last Earnings Report: Can It Continue?
• 4. Juni ·

  Yahoo
  BEAM Up on FDA's Orphan Drug Status for Gene-Editing Therapy
• 3. Juni ·

  Yahoo
  Beam Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to BEAM-101 for the Treatment of Sickle Cell Disease
• 30. Mai ·

  Yahoo
  FDA Grants Orphan Drug Status to Beam Therapeutics Inc. (BEAM)’ AATD Gene Therapy
• 29. Mai ·

  SeekingAlpha
  Beam Therapeutics: A Cautious Hold On A Base Editing Pioneer
• 13. Mai ·

  Yahoo
  Beam Therapeutics to Participate in 2025 RBC Capital Markets Global Healthcare Conference